Core Insights - Brain-computer interface (BCI) technology is gaining attention due to demonstrations by Neuralink, with Chinese company Huazhong Brain Control (Huazhong) exploring new paths for commercialization [1] - Huazhong has developed non-invasive BCI technology that has quickly transitioned to market, with applications in elderly care, mental health, and more [1] - The Greater Bay Area's geographical and policy advantages are facilitating Huazhong's collaborative development [1] Company Developments - Huazhong's chairman, Li Yuanqing, stated that multiple non-invasive BCI products have been launched, covering various fields such as elderly care, mental health, military aerospace, public safety, cultural entertainment, and education [1] - The company has introduced products like brain-controlled mice, wheelchairs, and the first non-drug wearable mindfulness meditation device in China, which has received top ratings on Amazon [1] - Li highlighted the significant population of elderly individuals and those with mental health issues in China, indicating a vast market for BCI technology [1] Industry Context - The Greater Bay Area's educational, medical, and industrial chain advantages have empowered Huazhong, allowing for efficient R&D to production processes [2] - The South China region, particularly Nansha, is seen as a promising area for development due to its strategic location and strong innovation ecosystem [2] - Nansha's strategic emerging industries have increased their GDP contribution to 37.8%, with R&D investment intensity rising to 5.48% and a 21.5% annual growth in high-tech enterprises, totaling 1,310 [2]